Current Controversies: Which Patients With Acute Myeloid Leukaemia Should Receive A Bone Marrow Transplantation? - An Adult Treater's View
- 25 July 2002
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 118 (2), 357-364
- https://doi.org/10.1046/j.1365-2141.2002.03698.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trialBritish Journal of Haematology, 2002
- Conditioning regimens for allogeneic stem cell transplantsCurrent Opinion in Hematology, 2000
- Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC TrialBlood, 1999
- Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First RemissionNew England Journal of Medicine, 1998
- Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trialThe Lancet, 1998
- Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 GroupBlood, 1993
- Reasons That Patients with Acute Myelogenous Leukemia Do Not Undergo Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]Blood, 1990
- Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-upBlood, 1988
- TRANSPLANTATION OF UNPURGED AUTOLOGOUS BONE-MARROW IN ACUTE MYELOID LEUKAEMIA IN FIRST REMISSIONThe Lancet, 1984